Abstract:To investigate the effect of ectopic high expression of OCT4 on the stemness characteristics of bone marrow-derived mesenchymal stromal cells (BM-MSCs). BM-MSCs were collected from three de novo acute lymphoblastic leukemia (ALL) and three aplastic anemia patients (AA), which were cultivated by the whole bone marrow adherent method. Surface markers of BM-MSCs were analyzed by flow cytometry (FCM); meanwhile, growth characteristics were observed with a phase contrast microscope, and population doubling time (PDT) was calculated. The optimal generation cells (P4) were used for the subsequent experiments. Recombinant plasmid pcDNA3.1-OCT4 was constructed and transferred into ALL MSCs by liposome transfection. The cells with stable and high expression of OCT4 were selected by G418 resistance screening and subcloning, of which the expression of OCT4 was verified by FCM, cellular immunofluorescence assay (CIFA), and RT-PCR. The expression of stemness-related transcription factors (TFs) (NANOG, SOX2) and the embryonic stem cell (ESC)-related surface markers (SSEA4, TRA-1-60, and TRA-1-81) were analyzed by FCM, RT-PCR, and CIFA. Embryonic body (EB) formation was performed with the above cells, and triembryonic differentiation marker genes were evaluated by RT-PCR. The primary passage of AA MSCs grew more slowly and had longer PDT (16 days on average) than ALL MSCs (10 days on average). AA MSCs presented the same typical morphology and similar expression levels of specific mesenchymal markers as ALL MSCs, whereas the latter had a much better proliferative capacity in P4 cells (P < 0.05). Besides, the expression levels of surface markers in ALL MSCs were slightly higher than that in AA MSCs in P4, P7, and P10 cells (P < 0.05). Cell lines with stable and high expression of OCT4 were successfully established from ALL MSCs, which were confirmed by CIFA, FCM, and RT-PCR. Compared with untransfected parental MSCs, the mean expression levels of TFs in OCT4 overexpression MSCs were increased from 0.63 ± 0.37% to 39.39 ± 1.85% (NANOG) and from 14.34 ± 2.44% to 91.45 ± 4.56% (SOX2). The average expression levels of ESC surface markers were increased from 3.33 ± 2.35%, 1.59 ± 1.29%, and 1.46 ± 0.86% to 84.98 ± 9.2%, 57.28 ± 6.72%, and 75.88 ± 7.35% respectively for SSEA-4, TRA-1-60, and TRA-1-81, which were confirmed by CIFA analysis. Moreover, the OCT4 overexpression MSCs could form EBs ex vivo and express ectoderm (TUBB3, WNT1), mesoderm (Brachyury, TBX20), and endoderm (SPARC) genes. Ectopic high expression of transcription factor OCT4 in BM-MSCs may drive them to grow as ESC-like cells with “stemness” characteristics. Single OCT4 transfection can upregulate the expression of other stemness-related transcription factors such as NANOG and SOX2.

Expression of OCT-4 and SOX-2 in Bone Marrow-Derived Human Mesenchymal Stem Cells during Osteogenic Differentiation

[Effect of OCT4 Gene Expression Upregulation on the Expression of Ipsc-Related Transcription Factors in Human Bone Marrow Derived Mesenchymal Stem Cells].

Effect of Ectopic High Expression of Transcription Factor OCT4 on the “stemness” Characteristics of Human Bone Marrow-Derived Mesenchymal Stromal Cells

Introduction of OCT4 into Human Bone-Marrow Derived Mesenchymal Stromal Cells Generates Putative Ips Cells with the Potential to Differentiate into CD34+ Hematopoietic Progenitor Cells Ex Vivo

Identification of differentiation-stage specific markers that define the ex vivo osteoblastic phenotype

Ex Vivo Expansion and Pluripotential Differentiation of Cryopreserved Bone Marrow Mesenchymal Stem Cells

Ex Vivo Expansion and Pluripotential Differentiation of Cryopreserved Human Bone Marrow Mesenchymal Stem Cells

Embryonic Stem Cell Marker Expression Pattern in Human Mesenchymal Stem Cells Derived from Bone Marrow, Adipose Tissue, Heart and Dermis

[Changes of Microrna and Target Gene Expression Levels in Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells].

Gas Chromatography-Mass Spectrometry Analysis of Human Mesenchymal Stem Cell Metabolism During Proliferation and Osteogenic Differentiation under Different Oxygen Tensions.

Study of differentiation of adult human mesenchymal stem cells toward ostesblasts in vitro

Gene expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation

Proteomic Identification of Differently Expressed Proteins Responsible for Osteoblast Differentiation from Human Mesenchymal Stem Cells

Gene expression analysis of human adipose tissue-derived stem cells during the initial steps of in vitro osteogenesis

Establishing a Deeper Understanding of the Osteogenic Differentiation of Monolayer Cultured Human Pluripotent Stem Cells Using Novel and Detailed Analyses

The Gene Expression Patterns of Bone-marrow Mesenchymal Stem Cells under Different Osteogenic Induction

Osteogenic Differentiation Gene Expression Profiling of Hmscs on Hydroxyapatite and Mineralized Collagen.

Mesenchymal stem cells of different origin: Comparative evaluation of proliferative capacity, telomere length and pluripotency marker expression

Hypoxia Inhibiting the Osteogenic Differentiation of Adult Human Mesenchymal Stem Cells in vitro

Experimental Research on hMSCs Isolation,Culture and its Induced Differentiation into Osteoblasts

A preliminary study of in vitro osteogenesis of culture-expanded,bone marrow-derived adult human mesenchymal stem cells